Selected article for: "health care and paper aim"

Author: Sendzikaite, Skaiste; Heying, Ruth; Milanesi, Ornella; Hanseus, Katarina; Michel-Behnke, Ina
Title: COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper
  • Cord-id: 92inimte
  • Document date: 2021_1_7
  • ID: 92inimte
    Snippet: The COVID-19 pandemic has had a huge influence in almost all areas of life, affecting societies, economics, and health care systems worldwide. The paediatric cardiology community is no exception. As the challenging battle with COVID-19 continues, professionals from the Association for the European Paediatric and Congenital Cardiology receive many questions regarding COVID-19 in a Paediatric and Congenital Cardiology setting. The aim of this paper is to present the AEPC position on frequently ask
    Document: The COVID-19 pandemic has had a huge influence in almost all areas of life, affecting societies, economics, and health care systems worldwide. The paediatric cardiology community is no exception. As the challenging battle with COVID-19 continues, professionals from the Association for the European Paediatric and Congenital Cardiology receive many questions regarding COVID-19 in a Paediatric and Congenital Cardiology setting. The aim of this paper is to present the AEPC position on frequently asked questions based on the most recent scientific data, as well as to frame a discussion on how to take care of our patients during this unprecedented crisis. As the times are changing quickly and information regarding COVID-19 is very dynamic, continuous collection of evidence will help guide constructive decision-making.

    Search related documents:
    Co phrase search for related documents
    • acetylsalicylic acid and acute kidney injury: 1
    • acetylsalicylic acid and acute phase: 1
    • acetylsalicylic acid and low dose acetylsalicylic acid: 1, 2, 3, 4, 5
    • acetylsalicylic acid and low dose aspirin: 1
    • acetylsalicylic acid and low molecular: 1, 2, 3, 4, 5
    • acetylsalicylic acid and low molecular weight: 1, 2, 3, 4, 5
    • acetylsalicylic acid and low molecular weight heparin: 1, 2, 3, 4
    • acetylsalicylic acid and macrophage activation: 1, 2
    • acetylsalicylic acid and macrophage activation syndrome: 1, 2
    • acid dependent and acute infection: 1, 2
    • acid dependent and lung disease: 1, 2
    • acid dependent and macrophage activation: 1
    • acid polymerase and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acid polymerase and lopinavir ritonavir: 1, 2, 3
    • acid polymerase and low normal: 1
    • acid polymerase and low number: 1, 2